Topiramate IV: Enhanced Method of Administration in Babies, Older Children and Adults

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

New Formulations and Indications

Phase Of Development

Preclinical

Sponsors and Collaborators

University of Minnesota; Ligang Pharmaceuticals (formerly CyDex), EF

Mechanism of Action

Mechanism Description

Toprimate extended release

Populations Tested In

For those taking Topiramate who end up in hospital

Other Resources

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - NTCG 2014

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.